A detailed history of Marco Investment Management LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Marco Investment Management LLC holds 6,702 shares of NVO stock, worth $585,553. This represents 0.07% of its overall portfolio holdings.

Number of Shares
6,702
Previous 6,602 1.51%
Holding current value
$585,553
Previous $942,000 15.29%
% of portfolio
0.07%
Previous 0.09%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$119.07 - $145.42 $11,907 - $14,541
100 Added 1.51%
6,702 $798,000
Q1 2024

May 08, 2024

BUY
$102.11 - $135.92 $15,520 - $20,659
152 Added 2.36%
6,602 $847,000
Q3 2023

Nov 07, 2023

BUY
$90.94 - $199.54 $293,281 - $643,516
3,225 Added 100.0%
6,450 $586,000
Q2 2023

Aug 14, 2023

SELL
$155.98 - $172.65 $93,588 - $103,590
-600 Reduced 15.69%
3,225 $521,000
Q1 2023

May 11, 2023

SELL
$132.34 - $159.14 $33,085 - $39,785
-250 Reduced 6.13%
3,825 $608,000
Q4 2022

Feb 13, 2023

BUY
$102.55 - $135.33 $25,637 - $33,832
250 Added 6.54%
4,075 $551,000
Q1 2022

May 11, 2022

SELL
$93.1 - $112.54 $2,979 - $3,601
-32 Reduced 0.83%
3,825 $425,000
Q4 2021

Feb 14, 2022

BUY
$95.88 - $117.08 $3,068 - $3,746
32 Added 0.84%
3,857 $432,000
Q4 2019

Feb 11, 2020

BUY
$49.86 - $58.26 $190,714 - $222,844
3,825 New
3,825 $221,000
Q2 2019

Aug 06, 2019

SELL
$46.79 - $52.47 $178,971 - $200,697
-3,825 Closed
0 $0
Q1 2019

May 02, 2019

BUY
$46.36 - $52.63 $177,327 - $201,309
3,825 New
3,825 $200,000
Q1 2018

May 01, 2018

SELL
$48.49 - $58.14 $185,474 - $222,385
-3,825 Closed
0 $0
Q4 2017

Feb 15, 2018

BUY
$47.53 - $53.73 $181,802 - $205,517
3,825
3,825 $205,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Marco Investment Management LLC Portfolio

Follow Marco Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marco Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Marco Investment Management LLC with notifications on news.